SCOPE: Evaluation and management of headache due to low cerebrospinal fluid pressure in adults. Covers spontaneous intracranial hypotension (SIH), post-lumbar puncture headache (PDPH), and post-surgical/post-traumatic CSF leaks. Includes diagnostic workup (MRI brain, MRI spine, CT myelography, cisternography), conservative management, epidural blood patch, and surgical repair for refractory cases. Excludes cranial CSF rhinorrhea/otorrhea from skull base defects (managed by otolaryngology/neurosurgery), and CSF leaks secondary to VP shunt overdrainage.
DEFINITIONS:
Spontaneous Intracranial Hypotension (SIH): Low CSF pressure (<6 cm H2O) or CSF hypovolemia from spontaneous spinal CSF leak, causing orthostatic headache and characteristic MRI findings
Post-Dural Puncture Headache (PDPH): Headache occurring within 5 days of lumbar puncture or spinal anesthesia, typically orthostatic, due to persistent dural rent and CSF leak
Orthostatic Headache: Headache that worsens significantly within 15 minutes of assuming upright posture and improves within 15-30 minutes of recumbency
Epidural Blood Patch (EBP): Injection of autologous blood into the epidural space to seal a dural defect and restore CSF volume
Pachymeningeal Enhancement: Diffuse, smooth, non-nodular dural enhancement on gadolinium-enhanced MRI, characteristic of intracranial hypotension
CSF Hypovolemia: Reduction in total CSF volume causing brain sagging and traction on pain-sensitive structures, even when opening pressure may be normal
Dural Ectasia: Weakness and ballooning of the dural sac, often associated with connective tissue disorders, predisposing to CSF leaks
CSF-Venous Fistula: Abnormal connection between a spinal nerve root sleeve and an adjacent epidural vein, causing CSF drainage into the venous system
PRIORITY KEY: STAT = Immediate | URGENT = Within hours | ROUTINE = Standard | EXT = Extended/atypical cases | - = Not applicable to this setting
Indication: Confirm low CSF pressure (opening pressure <6 cm H2O diagnostic; may be normal in 20-30% of SIH); obtain CSF to rule out meningitis or other causes of meningeal enhancement; therapeutic in IIH (NOT therapeutic in SIH - do not drain CSF)
Timing: URGENT if diagnosis uncertain and need to differentiate from meningitis; ROUTINE for elective diagnosis; CAUTION: LP can worsen symptoms in SIH patients and is often deferred if MRI findings are classic
Volume Required: 1-3 mL only (minimal volume; do NOT perform large-volume LP in suspected SIH)
Study
Rationale
Target Finding
ED
HOSP
OPD
ICU
Opening pressure
Diagnostic criterion for intracranial hypotension; <6 cm H2O diagnostic but may be normal (0-6 cm H2O supports diagnosis)
<6 cm H2O (may be 0 or negative; normal in 20-30%)
URGENT
URGENT
ROUTINE
URGENT
Cell count (tubes 1 and 4) (CPT 89051)
Rule out meningitis or SAH; SIH may show mild pleocytosis (<5-50 WBC)
WBC <5 typical; mild elevation possible in SIH
URGENT
URGENT
ROUTINE
URGENT
Protein (CPT 84157)
Often mildly elevated in SIH (45-100 mg/dL) due to meningeal irritation; rule out infection
Normal 15-45 mg/dL; mildly elevated in SIH is expected
URGENT
URGENT
ROUTINE
URGENT
Glucose with serum glucose (CPT 82945)
Rule out infectious meningitis
Normal (>60% of serum glucose)
URGENT
URGENT
ROUTINE
URGENT
Gram stain and culture (CPT 87205, 87070)
Rule out bacterial meningitis if fever or meningismus present
No organisms
URGENT
URGENT
-
URGENT
RBC count (CPT 89051)
Rule out traumatic tap vs. xanthochromia from chronic SIH-related subdural collections
Document; xanthochromia may occur in SIH
URGENT
URGENT
ROUTINE
URGENT
Special Handling: Measure opening pressure with patient in lateral decubitus, legs extended, relaxed; use smallest gauge needle possible (22G or smaller) to minimize additional leak risk
Contraindications: LP may worsen SIH symptoms; defer if MRI brain findings are classic for SIH; mass lesion; coagulopathy (INR >1.5, platelets <50,000); local infection at puncture site
200 mg q6h :: PO :: q6h PRN :: 200-300 mg PO q6h (coffee ~100 mg/cup); max 900 mg/day; adjunct to other measures
Cardiac arrhythmia, severe anxiety, insomnia
Heart rate, sleep quality, anxiety
URGENT
ROUTINE
ROUTINE
-
Strict bed rest (Trendelenburg)
-
Reduce hydrostatic pressure across dural defect; facilitate seal
Flat or Trendelenburg position :: - :: continuous :: Strict bed rest in supine or slight Trendelenburg (10-15 degrees) for 24-48 hours initially; allow bathroom privileges only
DVT risk with prolonged immobility
DVT prophylaxis, skin integrity
STAT
STAT
-
STAT
Abdominal binder
-
Increase intra-abdominal and epidural venous pressure to tamponade leak
Apply snugly :: - :: continuous :: Apply abdominal binder continuously while upright; may improve symptoms by increasing epidural pressure
Abdominal surgery, respiratory compromise
Respiratory comfort, skin integrity
URGENT
ROUTINE
ROUTINE
-
Acetaminophen
PO
Headache symptom relief
1000 mg q6h :: PO :: q6h PRN :: 1000 mg PO q6h PRN headache; max 3000 mg/day
Hepatic disease, chronic alcohol use >3 drinks/day
LFTs if prolonged use
URGENT
ROUTINE
ROUTINE
-
Ibuprofen
PO
Headache and meningeal inflammation relief
400 mg q6h :: PO :: q6h PRN :: 400-600 mg PO q6h PRN; max 2400 mg/day; take with food
Renal disease, GI bleeding, anticoagulation, aspirin allergy
Renal function, GI symptoms
URGENT
ROUTINE
ROUTINE
-
Ondansetron
IV/PO
Nausea associated with orthostatic symptoms and SIH
4 mg q8h PRN :: IV :: q8h PRN :: 4-8 mg IV or PO q8h PRN nausea; max 24 mg/day
QT prolongation, severe hepatic impairment
QTc if repeated dosing
URGENT
ROUTINE
ROUTINE
-
Docusate sodium
PO
Prevent straining during bed rest which can worsen CSF leak
100 mg BID :: PO :: BID :: 100 mg PO BID; continue throughout bed rest period and until regular activity resumes
Intestinal obstruction
Bowel frequency
-
ROUTINE
ROUTINE
-
Enoxaparin
SC
DVT prophylaxis during prolonged bed rest in hospitalized SIH patients
40 mg daily :: SC :: daily :: 40 mg SC daily; begin within 24 hours of admission if on bed rest >48 hours; hold 12 hours before and after epidural blood patch
Active bleeding, HIT, severe renal impairment (CrCl <30: reduce to 30 mg daily), coagulopathy, within 12 hours of EBP
Platelet count q2-3 days; signs of bleeding; renal function
First-line definitive treatment for PDPH and SIH; seals dural defect with autologous blood clot
15-30 mL autologous blood :: Epidural :: once :: Inject 15-30 mL autologous blood into lumbar or thoracolumbar epidural space under fluoroscopy; patient lies flat 1-2 hours post-procedure; ~70-90% PDPH success rate; ~30-50% SIH success rate on first attempt
Active systemic infection/bacteremia, local skin infection, coagulopathy (INR >1.5, platelets <50K), patient refusal
Vital signs during and 1h post-procedure; neurologic exam; pain at injection site; radicular symptoms (transient acceptable)
URGENT
URGENT
ROUTINE
-
Epidural blood patch - targeted (CPT 62273)
Epidural
SIH after leak localization by CT myelography or MRI spine; targeted to level of leak
15-30 mL autologous blood :: Epidural :: once :: Inject 15-30 mL autologous blood at or near identified leak level under fluoroscopic or CT guidance; higher success rate for SIH when targeted; may require multi-level injection
Active systemic infection/bacteremia, local skin infection, coagulopathy (INR >1.5, platelets <50K), patient refusal
Vital signs during and 1h post-procedure; neurologic exam; radicular symptoms; headache improvement within 24-72 hours
-
URGENT
ROUTINE
-
Repeat epidural blood patch
Epidural
Persistent symptoms after initial EBP; may attempt 2-3 times before escalating
20-30 mL autologous blood :: Epidural :: once :: Repeat EBP 5-7 days after first attempt if symptoms persist; may use larger volume (up to 30 mL); consider targeted approach if not done initially
Active systemic infection/bacteremia, local skin infection, coagulopathy (INR >1.5, platelets <50K), patient refusal
Vital signs during and 1h post-procedure; neurologic exam; consider leak localization if second EBP fails
Adjunctive treatment for SIH; increases CSF production via adenosine receptor antagonism
200 mg BID :: PO :: BID :: Start 200 mg PO BID; titrate to 300 mg BID based on serum levels; target serum level 10-15 mcg/mL; may take 1-2 weeks for effect
Seizure disorder, cardiac arrhythmia, active peptic ulcer, hepatic impairment
Theophylline level q2-4 weeks initially; heart rate; GI symptoms; drug interactions (CYP1A2)
-
ROUTINE
ROUTINE
-
Hydrocortisone
IV
Refractory SIH not responding to EBP; anti-inflammatory effect on meninges; may increase CSF production
200 mg daily :: IV :: daily :: 200 mg IV on day 1 then taper: 200 mg IV daily x 2d, 150 mg x 2d, 100 mg x 2d, then convert to oral; total course 7-14 days
Active untreated infection, uncontrolled diabetes
Blood glucose q6h, blood pressure, electrolytes
-
URGENT
-
URGENT
Prednisone (oral taper)
PO
Outpatient management of refractory SIH; meningeal inflammation
60 mg daily :: PO :: daily :: 60 mg PO daily x 5 days, then taper by 10 mg every 3-5 days over 3-4 weeks
Active untreated infection, uncontrolled diabetes, GI bleeding
Blood glucose, blood pressure, mood, GI symptoms
-
ROUTINE
ROUTINE
-
Gabapentin
PO
Neuropathic headache component; adjunctive pain management in SIH
300 mg qHS :: PO :: qHS then TID :: Start 300 mg PO qHS; titrate by 300 mg q3-5d; target 900-1800 mg/day divided TID; max 3600 mg/day
Severe renal impairment (adjust dose)
Sedation, dizziness, peripheral edema
-
ROUTINE
ROUTINE
-
Pregabalin
PO
Alternative to gabapentin for neuropathic pain component
75 mg BID :: PO :: BID :: Start 75 mg PO BID; increase to 150 mg BID after 1 week; max 300 mg BID
Severe renal impairment (adjust dose), angioedema history
Refractory SIH after failed EBP (2-3 attempts); seals dural defect with fibrin sealant
Fibrin sealant at leak site :: Epidural :: once :: Inject fibrin glue (e.g., Tisseel) at identified leak site under fluoroscopic or CT guidance; may combine with blood patch; performed by anesthesia or interventional radiology
Active infection, known allergy to fibrin/bovine components, coagulopathy
Precisely localized leak refractory to EBP; allows direct placement at dural defect
Fibrin sealant via CT-guided needle :: Percutaneous :: once :: CT-guided needle placement at leak site followed by fibrin glue injection; requires interventional radiology expertise
Active infection, coagulopathy, inability to identify leak site
Post-procedure neuro exam; imaging follow-up
-
EXT
EXT
-
Surgical dural repair
Surgical
Definitive treatment for identified dural tear or meningeal diverticulum refractory to all conservative and percutaneous therapies
Surgical exploration and primary dural repair :: - :: once :: Open or minimally invasive surgical repair of dural defect; may include muscle/fascia graft; requires neurosurgical expertise; hospitalization 3-7 days
Confirmed CSF-venous fistula on DSM; increasingly recognized cause of refractory SIH
Surgical ligation or transvenous embolization :: - :: once :: Surgical ligation of fistulous nerve root sleeve; or transvenous embolization of draining vein; requires specialized center
Unable to confirm fistula, coagulopathy for surgery
Post-procedure neuro exam; repeat imaging to confirm resolution
-
EXT
EXT
-
Continuous epidural saline infusion
Epidural
Bridge therapy while awaiting definitive treatment; refractory symptoms
NS at 20-50 mL/hr :: Epidural :: continuous :: Continuous epidural normal saline infusion at 20-50 mL/hr via epidural catheter; temporary measure for severe refractory symptoms
Epidural infection, coagulopathy
Catheter site infection, neurologic exam, headache response
-
EXT
-
EXT
Intrathecal saline infusion
Intrathecal
Severe refractory SIH as bridge to definitive repair; restores CSF volume temporarily
NS at 15-30 mL/hr :: Intrathecal :: continuous :: Intrathecal normal saline via lumbar drain at 15-30 mL/hr; temporary measure only; risk of infection increases with duration
3E. Subdural Hematoma Management (Complication of SIH)¶
Treatment
Route
Indication
Dosing
Contraindications
Monitoring
ED
HOSP
OPD
ICU
Observation with serial imaging
-
Small, asymptomatic subdural collections; most resolve after CSF leak treatment
Serial CT head q1-2 weeks :: - :: per protocol :: Most subdural hygromas/hematomas resolve after successful treatment of underlying CSF leak; avoid surgical evacuation if possible
None
Neuro checks, serial CT, symptom progression
URGENT
ROUTINE
ROUTINE
URGENT
Epidural blood patch (treat underlying cause)
Epidural
Subdural collections secondary to SIH; treating the leak often resolves the subdural
15-30 mL autologous blood :: Epidural :: once :: EBP should be performed BEFORE considering surgical evacuation; inject 15-30 mL autologous blood into epidural space under fluoroscopy; SDH from SIH often recurs after drainage if leak not addressed
Active systemic infection/bacteremia, local skin infection, coagulopathy (INR >1.5, platelets <50K), patient refusal
Vital signs during and 1h post-procedure; neurologic exam; serial CT for SDH
URGENT
URGENT
ROUTINE
-
Neurosurgical evacuation
Surgical
Large symptomatic SDH with mass effect or neurologic deterioration not responding to CSF leak treatment
Burr hole or craniotomy :: - :: once :: Surgical evacuation only if mass effect, midline shift >5 mm, or declining mental status AND CSF leak has been addressed; high recurrence if leak untreated
Remain flat or in Trendelenburg position as much as possible to reduce headache while awaiting definitive treatment (upright posture worsens symptoms)
ROUTINE
ROUTINE
ROUTINE
-
Increase oral fluid intake to at least 2-3 liters daily to support CSF production and hydration
ROUTINE
ROUTINE
ROUTINE
-
Increase caffeine intake (coffee, tea) to 300-500 mg/day as this constricts cerebral blood vessels and may reduce headache
ROUTINE
ROUTINE
ROUTINE
-
Avoid Valsalva maneuvers (straining, heavy lifting, coughing) which can worsen or re-open CSF leaks
ROUTINE
ROUTINE
ROUTINE
-
After epidural blood patch: lie flat for 1-2 hours post-procedure, then gradually increase activity over 24-48 hours; avoid heavy lifting for 2-4 weeks
-
ROUTINE
ROUTINE
-
Return to ED immediately if headache suddenly becomes the worst headache of life, new neurologic symptoms develop (weakness, numbness, vision changes, confusion), or fever occurs (may indicate subdural hematoma, meningitis, or abscess)
ROUTINE
ROUTINE
ROUTINE
-
Some patients have persistent headache after successful leak treatment; this typically improves over weeks to months
-
ROUTINE
ROUTINE
-
Follow up with neurology in 1-2 weeks after epidural blood patch to assess response and plan further workup if needed
Mild orthostatic headache responsive to oral analgesics and caffeine; able to tolerate PO; no red flags (new neurologic deficits, fever, worst headache of life); outpatient MRI and neurology follow-up within 1 week arranged
Admit to hospital (floor)
Severe orthostatic headache preventing ambulation or oral intake; need for IV hydration and caffeine; scheduled for epidural blood patch; new diagnosis of SIH requiring urgent MRI and workup; concern for subdural hematoma
Admit to hospital (observation)
Post-dural puncture headache not responding to conservative measures after 24-48 hours; awaiting epidural blood patch
Neurosurgery/ICU transfer
Large subdural hematoma with mass effect or neurologic deterioration; posterior fossa crowding from brain sagging with signs of brainstem compression
Discharge from hospital
Headache significantly improved (>50% reduction) after EBP or conservative treatment; tolerating oral medications; able to ambulate; close outpatient follow-up arranged within 1-2 weeks
Outpatient management
Mild symptoms manageable with oral analgesics and caffeine; able to maintain hydration; no red flags; MRI brain already obtained or scheduled; neurology follow-up within 1-2 weeks
Outpatient follow-up schedule
Post-EBP: 1-2 weeks; Refractory SIH: weekly until improved; After resolution: 3 months then annually for 1-2 years to monitor for recurrence
CSF opening pressure may be normal in 20-30% of SIH patients
Class III, Level B
Schievink WI et al. Diagnostic criteria for headache due to spontaneous intracranial hypotension. Headache 2011 PubMed: 21658029
Targeted EBP has higher success rate than blind EBP for SIH
Class III, Level B
Kranz PG et al. CT-guided epidural blood patching of directly observed or potential leak sites for the targeted treatment of spontaneous intracranial hypotension. AJNR Am J Neuroradiol 2011 PubMed: 21349964
Fibrin glue sealant effective for refractory CSF leaks
Class III, Level C
Schievink WI et al. Treatment of spontaneous intracranial hypotension with percutaneous placement of fibrin sealant. J Neurosurg 2004 PubMed: 15200130
Surgical repair for refractory dural defects
Class III, Level C
Schievink WI et al. Surgical treatment of spontaneous spinal cerebrospinal fluid leaks. J Neurosurg 1998 PubMed: 9452231
Brain sagging on MRI correlates with clinical severity
Class III, Level B
Savoiardo M et al. Spontaneous intracranial hypotension with deep brain swelling. Brain 2007 PubMed: 17535837
Connective tissue disorders (EDS, Marfan) predispose to SIH
Class III, Level B
Schievink WI et al. Connective tissue disorders with spontaneous spinal CSF leaks and intracranial hypotension. Neurosurgery 2004 PubMed: 14683542
Subdural hematomas complicate SIH and often resolve after leak treatment
Class III, Level B
De Noronha RJ et al. Subdural haematoma: a potentially serious consequence of spontaneous intracranial hypotension. J Neurol Neurosurg Psychiatry 2003 PubMed: 12754345
CSF-venous fistulas are an underrecognized cause of SIH
Class III, Level C
Schievink WI et al. A classification system of spontaneous spinal CSF leaks. Neurology 2016 PubMed: 27440149
Digital subtraction myelography is gold standard for CSF-venous fistula detection
Class III, Level C
Farb RI et al. Spontaneous intracranial hypotension: a systematic imaging approach for CSF leak localization and management. AJNR Am J Neuroradiol 2019 PubMed: 30923083
Theophylline may increase CSF production via adenosine receptor antagonism
Class III, Level C
Mokri B. Headaches caused by decreased intracranial pressure: diagnosis and management. Curr Opin Neurol 2003 PubMed: 12858068
Hydrocortisone/corticosteroids as adjunctive therapy for refractory SIH
Class III, Level C
Grimaldi D et al. Spontaneous low cerebrospinal pressure: a mini review. Neurol Sci 2004 PubMed: 15549523
ICHD-3 diagnostic criteria for headache attributed to low CSF pressure
Expert consensus
Headache Classification Committee of the International Headache Society. ICHD-3. Cephalalgia 2018 PubMed: 29368949
Intrathecal gadolinium MRI for slow leak detection
Class III, Level C
Akbar JJ et al. The role of MR myelography with intrathecal gadolinium in localization of spinal CSF leaks in patients with spontaneous intracranial hypotension. AJNR Am J Neuroradiol 2012 PubMed: 22173753
Kranz PG et al. Imaging signs in spontaneous intracranial hypotension: prevalence and relationship to CSF pressure. AJNR Am J Neuroradiol 2016 PubMed: 26869465
Continuous epidural saline infusion as bridge therapy
Case series
Bai J et al. Continuous epidural saline infusion for treatment of refractory spontaneous intracranial hypotension. Pain Physician 2017
SIH is often underdiagnosed; maintain high suspicion in any patient with new orthostatic headache
Classic triad: orthostatic headache, diffuse pachymeningeal enhancement on MRI, low CSF opening pressure (though OP may be normal in 20-30%)
MRI brain with gadolinium is the most important diagnostic test; do NOT rely on LP alone
PDPH typically self-resolves within 1-2 weeks; EBP indicated if symptoms persist beyond 24-48 hours or are severe
For SIH, blind EBP success rate is only 30-50% (vs. 70-90% for PDPH); targeted EBP after leak localization is preferred
CSF-venous fistulas are an increasingly recognized cause of SIH; require specialized imaging (digital subtraction myelography) for diagnosis
Subdural hematomas in SIH patients should be treated by addressing the underlying CSF leak first; surgical evacuation alone leads to high recurrence
LP in suspected SIH may worsen symptoms and should be deferred if MRI brain findings are classic; when performed, use smallest gauge needle and remove minimal volume
Connective tissue disorders (Ehlers-Danlos, Marfan) are risk factors; screen if recurrent or young patient
Rebound intracranial hypertension can occur after successful CSF leak treatment; monitor for new headache pattern (worse lying down)
Chronic SIH can lead to superficial siderosis from repeated microbleeding along the neuroaxis
v1.1 (January 30, 2026)
- Added ICU coverage across all applicable sections (labs, LP, imaging, acute treatment, monitoring, referrals) per S1
- Fixed cross-references in Section 3E: replaced "Per EBP protocol above", "Per EBP contraindications", and "Per EBP monitoring" with self-contained content per C1/R1
- Added PubMed citation links to all references in Section 8; corrected journal names for Savoiardo (Brain 2007), Schievink connective tissue (Neurosurgery 2004), Mokri theophylline (Curr Opin Neurol 2003), Grimaldi mini review (Neurol Sci 2004), and Kranz targeted EBP (AJNR 2011) per C3/R2
- Moved docusate sodium from Section 4C to Section 3A as proper medication row with structured dosing per R4/M5
- Added enoxaparin (DVT prophylaxis) to Section 3A with complete dosing and EBP timing precautions per R5/M6
- Fixed gabapentin dosing: single start dose (300 mg qHS) in structured field with titration in full instructions per R6/M2
- Fixed pregabalin dosing: single start dose (75 mg BID) in structured field with titration in full instructions per R7/M3
- Added rebound intracranial hypertension monitoring to Section 6 per R8
- Removed duplicate DVT prophylaxis entry from Section 4C (now covered by enoxaparin in 3A and compression stockings in 4C) per M6
- Updated version to 1.1 in frontmatter, VERSION line, and change log
v1.0 (January 30, 2026)
- Initial template creation
- Comprehensive diagnostic workup including MRI brain, MRI spine, CT myelography, cisternography, and digital subtraction myelography
- Conservative management with IV fluids, caffeine, bed rest, and abdominal binder
- Epidural blood patch protocol (blind and targeted)
- Pharmacologic adjuncts: theophylline, hydrocortisone, gabapentin, pregabalin
- Interventional options: fibrin glue, surgical dural repair, CSF-venous fistula treatment
- Subdural hematoma management in SIH context
- Lumbar puncture section with low-volume caution
- CSF-venous fistula recognition and treatment
- Connective tissue disorder screening guidance